Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

Outbreak Investigation of Salmonella: Moringa Leaf Powder

Outbreak Investigations & Safety Advisories
FDA Human Foods Program
The following is an update from FDA of concern to our subscribers.

CDC declares outbreak over. FDA’s investigation is complete.

The FDA and CDC, in collaboration with state and local partners, investigated illnesses in a multistate outbreak of Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis, MO. As of July 17, 2026, CDC has declared this outbreak over.

Based on epidemiological information collected by CDC, a total of 34 people infected with the outbreak strain of Salmonella were reported from 14 states. Illnesses started on dates ranging from August 27, 2025, to June 21, 2026. One additional person reported eating the moringa capsules while breastfeeding. This woman’s infant was sick with the outbreak strain. Of the 17 people interviewed, 14 (82%) reported eating moringa powder capsules, including 11 who reported Mogo brand moringa capsules. Of 25 people with information available, 11 have been hospitalized. No deaths have been reported.

As part of this investigation, FDA and state partners conducted a traceback investigation, onsite inspections, and collected samples to determine a source of contamination. Based on traceback records, FDA learned that MOGO Moringa LLC sourced all of their moringa leaf powder from India.

FDA sent investigators to the ingredient supplier and manufacturer for MOGO Moringa LLC. At the conclusion of both inspections, observations citing deficiencies were issued to both facilities.

The Washington Department of Health collected an open container of MOGO-brand moringa powder capsules that was positive for the strain of Salmonella causing illnesses in this outbreak. Tennessee Department of Health collected an open container of MOGO-brand moringa powder capsules with the same strain of Salmonella as the outbreak strain. The Florida Department of Health also collected an open container of MOGO-brand moringa powder capsules which was positive for the same strain of Salmonella as the outbreak strain and one other strain of Salmonella.

To further protect public health, FDA has increased screening of imported moringa powder from India for Salmonella. Recalled product should no longer be available for sale but does have a long shelf life. Consumers should check their homes for recalled product and throw it away. FDA’s outbreak investigation is complete.

Read the full update.

Additional Information
Recalls, Outbreaks & Emergencies

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.